Immune-mediated pancytopenia induced by oxaliplatin: a case report (2010)
- Authors:
- Autor USP: HOFF, PAULO MARCELO GEHM - FM
- Unidade: FM
- DOI: 10.1111/j.1537-2995.2010.02600.x
- Subjects: IMUNOLOGIA CLÍNICA; NEOPLASIAS GÁSTRICAS; ADENOCARCINOMA (IMUNOLOGIA); MEDICAMENTO (EFEITOS ADVERSOS)
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2010
- Source:
- Título: Transfusion
- ISSN: 0041-1132
- Volume/Número/Paginação/Ano: v. 50, n. 7, p. 1453-1459, jul. 2010
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
WENDEL, Rita Fontão et al. Immune-mediated pancytopenia induced by oxaliplatin: a case report. Transfusion, v. 50, n. 7, p. 1453-1459, 2010Tradução . . Disponível em: https://doi.org/10.1111/j.1537-2995.2010.02600.x. Acesso em: 23 fev. 2026. -
APA
Wendel, R. F., Hoff, P. M., Lazar, A., Freitas, D., Novis, yana, Patach, P., et al. (2010). Immune-mediated pancytopenia induced by oxaliplatin: a case report. Transfusion, 50( 7), 1453-1459. doi:10.1111/j.1537-2995.2010.02600.x -
NLM
Wendel RF, Hoff PM, Lazar A, Freitas D, Novis yana, Patach P, Tsujita M, Balthazar A, Pierroti M, Wendel S. Immune-mediated pancytopenia induced by oxaliplatin: a case report [Internet]. Transfusion. 2010 ; 50( 7): 1453-1459.[citado 2026 fev. 23 ] Available from: https://doi.org/10.1111/j.1537-2995.2010.02600.x -
Vancouver
Wendel RF, Hoff PM, Lazar A, Freitas D, Novis yana, Patach P, Tsujita M, Balthazar A, Pierroti M, Wendel S. Immune-mediated pancytopenia induced by oxaliplatin: a case report [Internet]. Transfusion. 2010 ; 50( 7): 1453-1459.[citado 2026 fev. 23 ] Available from: https://doi.org/10.1111/j.1537-2995.2010.02600.x - Should patients with advanced colorectal cancer and ECOG 3/4 be treated with chemotherapy?
- Primary prevention of colorectal cancer: Myth or reality?
- Drogas moleculares
- Perspectivas no cuidado dos tumores gastrointestinais
- Obesidade e câncer
- Combination of capecitabine and oxaliplatin is an effective treatment option for advanced neuroendocrine tumors
- Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer
- Evidence-based recommendations for gastrointestinal cancers during the COVID-19 pandemic by the Brazilian Gastrointestinal Tumours Group
- Lack of association between ERCC1 expression in biliary tract malignancy and response to chemotherapy
- Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas
Informações sobre o DOI: 10.1111/j.1537-2995.2010.02600.x (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
